Cargando…
Human fetal liver cells for regulated ex vivo erythropoietin gene therapy
Possible risks and lack of donor livers limit application of liver transplantation. Liver cell transplantation is, at this moment, not a feasible alternative because engraftment in the liver is poor. Furthermore, there is also shortage of cells suitable for transplantation. Fetal liver cells are abl...
Autores principales: | El Filali, Ebtisam, Duijst, Suzanne, Hiralall, Johan K, Legrand, Nicolas, van Gulik, Thomas, Hoekstra, Ruurdtje, Seppen, Jurgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362349/ https://www.ncbi.nlm.nih.gov/pubmed/26015950 http://dx.doi.org/10.1038/mtm.2014.3 |
Ejemplares similares
-
Reduction of liver macrophage transduction by pseudotyping lentiviral vectors with a fusion envelope from Autographa californica GP64 and Sendai virus F2 domain
por: Markusic, David M, et al.
Publicado: (2009) -
Novel immortalized human fetal liver cell line, cBAL111, has the potential to differentiate into functional hepatocytes
por: Deurholt, Tanja, et al.
Publicado: (2009) -
End-stage liver failure: filling the treatment gap at the intensive care unit
por: Chamuleau, Robert A. F. M., et al.
Publicado: (2019) -
Biliverdin Reductase inhibitors did not improve severe unconjugated hyperbilirubinemia in vivo
por: van Dijk, Remco, et al.
Publicado: (2017) -
Improved oxygenation dramatically alters metabolism and gene expression in cultured primary mouse hepatocytes
por: Gilglioni, Eduardo H., et al.
Publicado: (2018)